Rituximab-induced nonspecific interstitial pneumonia like reaction in a patient with idiopathic thrombocytopenic purpura

Respiratory Medicine CME

Volumn 2, Issue 4, 2009, Pages 176-178

  Protopapadakis, Charalambos ^a   Antoniou, Katerina M ^a   Voloudaki, Argiro ^b   Samara, Katerina ^a   Proklou, Athanasia ^a   Margaritopoulos, Giorgos ^a   Siafakas, Nikolaos M ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Interstitial lung disease; Rituximab

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD OXYGENATION; BRONCHIECTASIS; CASE REPORT; CORTICOSTEROID THERAPY; COUGHING; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHILIA; FEVER; FOLLOW UP; HEMATOLOGY; HUMAN; HUMAN TISSUE; HYPOXEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; MULTIPLE CYCLE TREATMENT; OXYGEN BLOOD LEVEL; PHYSICAL EXAMINATION; PLEURA EFFUSION; PRIORITY JOURNAL; TACHYPNEA; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 70449530832     PISSN: 17550017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedc.2009.01.010     Document Type: Article

References (10)

1. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120 (2003) 574-596
2. Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 141 (2008) 149-169
3. Cines D.B., and Bussel J.B. How I treat idiopathic thrombocytopenic purpura. Blood 106 (2005) 2244-2251
4. Bienvenu J., Chvetzoff R., Salles G., Balter C., Tilly H., Herbrecht R., et al., Groupe d'Etude des Lymphomes de l'Adulte. Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J 2 (2001) 378-384
5. Genentech report, rixutan and pulmonary events, 2005.
6. Hainsworth J.D., Litchy S., Lamb M.R., Rodriguez G.I., Scroggin Jr. C., and Greco F.A. First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial. Clin Lymphoma 4 (2003) 36-42
7. Alexandrescu D.T., Dutcher J.P., O'Boyle K., Albulak M., Oiseth S., and Wiernik P.H. Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma. Leuk Lymphoma 45 (2004) 2321-2325
8. Wagner S.A., Mehta A.C., and Laber D.A. Rituximab-induced interstitial lung disease. Am J Hematol 82 (2007) 916-919
9. Kim K.M., Kim H.C., Jeon K.N., Kim H.G., Kang J.H., Hahm J.R., et al. Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma. Yonsei Med J 49 (2008) 155-158
10. Swords R., Nolan A., Fay M., Quinn J., O'Donnell R., and Murphy P.T. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab. Clin Lab Haematol 28 (2006) 57-59